• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cellceutix Corp

+ Add to Watchlist

C0C:GR

1.563 EUR 0.001 0.06%

As of 05:55:49 ET on 09/02/2014.

Snapshot for Cellceutix Corp (C0C)

Open: 1.563 Day's Range: 1.563 - 1.563 Volume: 0
Previous Close: 1.562 52wk Range: 1.027 - 1.800 1-Yr Rtn: +3.51%

Stock Chart for C0C

No chart data available.
  • C0C:GR 1.563
  • 1D
  • 1M
  • 1Y
1.562
Interactive C0C Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for C0C

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 168.85
Shares Outstanding (M) 108.03
30 Day Average Volume 67
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for C0C

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for C0C

Cellceutix Corporation is a development-stage biopharmaceutical company. The Company's current portfolio of product candidates in pre-clinical development includes anti-cancer agents targeting multiple tumors, candidate targeting rheumatoid arthritis, candidate with potential for indications of osteo-arthritis/asthma, candidate being developed for autism.

Leo EhrlichChairman/CEO/CFOKrishna MenonPres/Chief Scientific Ofcr/Founder
More Company Profile & Key Executives for C0C

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil